The impact of autoSCT on disease burden in patients with myeloma treated with quadruplet therapy Luciano Costa, MD, PhD, UAB School of Medicine, Birmingham, AL, discusses the importance of reducing the toxicities and risks associated with autologous stem cell transplantation (autoSCT) in patients with multiple myeloma, and further comments on trials evaluating the impact of […]

Read More

CAR T-Cell Therapy for Multiple Myeloma at Hadassah Hospital in Jerusalem 🏥 Medical Treatment at Hadassah Hospital in Jerusalem. ➡️Contact us: 📧 contact@hadassah.hospital WhatsApp: +972 54 807 9678 Facebook: https://www.facebook.com/HadassahMideast Under the guidance of Professor Polina Stepensky, Hadassah Hospital in Israel is providing CAR-T therapy to patients with relapsed/refractory multiple myeloma who have been unsuccessfully […]

Read More

CAR-T cell therapy for Multiple Myeloma in Israel Hadassah Hospital has teamed up with NexImmune, an American biotechnology company that specializes in immune-oncology therapies, to create its own patented CAR-T treatment called NXC-201. NXC-201 CAR-T therapy yielded a 90% overall response rate (ORR) in participants with relapsed/refractory multiple myeloma. https://israelihospitals.org.il/car-t-multiple-myeloma-hadassah-hospital-israel.html

Read More

Brian's Walk For The Cure – Multiple Myeloma Awareness 3/23/19 Check out some of the highlights from Brian’s Walk For The Cure – Multiple Myeloma Awareness that took place on 3/23/19. Thank you to all who joined us for Brian’s Walk For the Cure. We had a one mile walk that started at Jodie Baptist […]

Read More